Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes. Issue 7 (28th April 2022) - Pieber, Thomas R.; Aronson, Ronnie; Christiansen, Mark P.; Bode, Bruce; Junaidi, Khaled; Conoscenti, Valentina